Claims for Patent: 6,172,107
✉ Email this page to a colleague
Summary for Patent: 6,172,107
Title: | Entric-coated pharmaceutical compositions |
Abstract: | This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract. |
Inventor(s): | Haeberlin; Barbara (Riehen, CH), Mak; Ching-Pong (Therwil, CH), Meinzer; Armin (Buggingen, DE), Vonderscher; Jacky (Riedisheim, FR) |
Assignee: | Novartis AG (Basel, CH) |
Application Number: | 09/469,536 |
Patent Claims: |
1. A pharmaceutical composition comprising a mycophenolate salt, the composition being formulated to disintegrate selectively in the intestinal tract to release mycophenolate
there.
2. A method of immunosuppressing a subject which comprises administering a therapeutically effective amount of a composition of claim 1 to a subject in need of such immunosuppression, optionally with the simultaneous or separate administration another immunosuppressant, wherein the composition has an enteric coating. 3. A composition containing a composition of claim 1 and another immunosuppressant for simultaneous, sequential or separate administration, wherein the composition has an enteric coating. 4. A composition according to claim 1 wherein the salt is the mono-sodium salt. 5. A composition according to claim 1 wherein said composition further comprises another immunosuppressant. 6. The pharmaceutical composition of claim 1 wherein said composition has an enteric coating and is suitable as an immunosuppressant medicament. 7. The pharmaceutical composition of claim 6 wherein said composition further comprises a second immunosuppressant. 8. The pharmaceutical composition of claim 7 wherein said second immunosuppressant is cyclosporin. |